Every year, thousands of gynecology practices, primary care providers, and medical billing teams face the same question:
What is the correct ICD-10 code for a Pap smear?
The answer isn’t always straightforward.
A Pap smear is a screening or diagnostic procedure rather than a diagnosis itself. The reason for the encounter and the supporting clinical documentation determine which ICD-10-CM diagnosis code applies, so no single ICD-10 code fits every Pap smear visit.
A patient presenting for a routine annual well-woman examination may require a different diagnosis code than a patient undergoing cervical cancer screening or follow-up care after an abnormal Pap result.
In this 2026 coding guide, we’ll break down the most commonly used diagnosis codes for Pap smear encounters, explain when each code applies, review common coding mistakes, and share practical examples to help reduce claim denials and improve reimbursement accuracy.
What Is the ICD-10 Code for a Pap Smear?
ICD-10-CM classifies Pap smears using different codes based on the reason for the test and the clinical findings.
Instead, coders select a diagnosis code based on the following:
- The purpose of the visit
- Whether the encounter is preventive or diagnostic
- Provider documentation
- Whether abnormal findings are present
- Payer-specific billing requirements
The most commonly used diagnosis codes associated with Pap smear services in 2026 include:
| Clinical Scenario | ICD-10-CM Code |
| Routine gynecological examination without abnormal findings | Z01.419 |
| routine women’s health examination with abnormal findings | Z01.411 |
| Cervical cancer screening encounter | Z12.4 |
| Follow-up for abnormal cervical cytology | R87 Series |
| History of abnormal cervical findings | Appropriate history code based on documentation |
What Is a Pap Smear?
A Pap smear, often called a Pap test, is a screening procedure used to detect abnormal cervical cells that may develop into cervical cancer if left untreated.
Healthcare providers routinely perform Pap testing during the following visits, making it one of the most effective preventive services in women’s healthcare:
- Annual well-woman visits
- Preventive gynecological examinations
- Cervical cancer screening appointments
- Follow-up care for previous abnormal findings
- Women’s health preventive care programs
Because providers use Pap smears in different clinical situations, coders need to review the documentation carefully before assigning the correct diagnosis code.
ICD-10 Code Z01.419: Routine Gynecological Examination Without Abnormal Findings
Official Description
Z01.419 – Encounter for gynecological examination (general) (routine) without abnormal findings
Women’s healthcare providers report this diagnosis code more frequently than almost any other.
When Do Providers Use Z01.419?
Use Z01.419 when:
- The patient presents for a routine gynecological examination
- Documentation shows no abnormal findings
- Providers perform Pap smears as part of preventive visits.
- The encounter qualifies as an annual well-woman examination
Example
A 42-year-old patient presents for her annual well-woman exam. The healthcare provider performs a pelvic examination and Pap smear. The provider documents no abnormalities.
Diagnosis Code: Z01.419
Healthcare providers commonly use this code for:
- Annual gynecological exams
- Well-woman visits
- Preventive women’s health evaluations
- Routine gynecological screening encounters
ICD-10 Code Z01.411: Routine Gynecological Examination With Abnormal Findings
Official Description
Z01.411 – Encounter for gynecological examination (general) (routine) with abnormal findings
Assign this code when a provider identifies abnormalities during an otherwise routine gynecological examination.
When Should Z01.411 Be Used?
Report Z01.411 when:
- The healthcare provider performs a routine gynecological exam for the patient.
- The provider documents abnormal findings during the encounter
- Healthcare providers may recommend additional evaluation or follow-up.
Examples of Abnormal Findings
- Abnormal pelvic examination findings
- Cervical lesions
- Vaginal masses
- Clinically significant gynecological abnormalities
- Unexplained abnormal bleeding
Example
A patient presents for her annual well-woman examination. During the pelvic exam, the provider identifies a suspicious cervical lesion requiring further evaluation.
Primary Diagnosis: Z01.411
Additional Diagnosis: Code the specific abnormal finding when documented.
Providers and coders often make the mistake of reporting Z01.419 even when the medical record clearly documents abnormal findings.
ICD-10 Code Z12.4: Cervical Cancer Screening
Official Description
Z12.4 Encounter for screening for malignant neoplasm of cervix
Many coding errors occur when providers report Z01.419 despite clearly documented abnormal findings in the medical record.
When Is Z12.4 Appropriate?
Use Z12.4 when:
- The patient presents for cervical cancer screening
- The provider orders screening cervical cytology.
- The provider performs a screening Pap smear.
- The patient visits the provider specifically for preventive cancer screening.
Example
A patient schedules an appointment specifically for cervical cancer screening and Pap testing without a comprehensive preventive gynecological examination.
Diagnosis Code: Z12.4
What’s the Difference Between Z01.419 and Z12.4?
Many coding and billing professionals consider this one of the most common questions.
While both codes may involve a Pap smear, they represent different reasons for the encounter.
| Code | Purpose |
| Z01.419 | Routine gynecological examination without abnormal findings |
| Z12.4 | Cervical cancer screening encounter |
Think of it this way:
- Z01.419 describes the preventive gynecological examination.
- Z12.4 describes the cervical cancer screening purpose.
Documentation and payer requirements determine which diagnosis code should be reported.
Because payer guidelines may vary, providers should review current CMS guidance and individual payer policies before submitting claims involving preventive women’s health services.
Coding for Abnormal Pap Smear Results
When cervical cytology results are abnormal, diagnosis coding should reflect the documented findings.
The R87 category is commonly used for abnormal cervical cytology findings.
Commonly Reported R87-Series Codes
| ICD-10-CM Code | Description |
| R87.610 | ASC-US |
| R87.611 | ASC-US favor dysplasia |
| R87.612 | Low-grade squamous intraepithelial lesion (LSIL) |
| R87.613 | High-grade squamous intraepithelial lesion (HSIL) |
| R87.619 | Unspecified abnormal cervical cytology |
Always code to the highest level of specificity supported by provider documentation.
Follow-Up Visits After an Abnormal Pap Smear
Patients frequently return for repeat testing, surveillance, or follow-up care after receiving abnormal cervical cytology results.
Diagnosis code selection depends on:
- The patient’s clinical history
- Current findings
- Reason for the encounter
- Provider documentation
Coding professionals should carefully review medical records to ensure that both current and historical conditions are accurately represented.
Gynecological Exam vs. Pap Smear: Understanding the Difference
One of the most common coding misconceptions is treating a Pap smear and a gynecological exam as the same service.
They are not.
A routine gynecological examination may include:
- Medical history review
- Pelvic examination
- Breast examination
- Preventive counseling
- Cervical cancer screening
- Pap testing
The diagnosis code should reflect the primary reason for the encounter—not simply the individual service performed.
Read: What Is RX PCN on an Insurance Card? Meaning, Location, and Importance Explained
Common Pap Smear Coding Mistakes
Even experienced practices occasionally encounter denials related to preventive women’s health services.
Here are some of the most common errors.
1. Reporting Z01.419 When Abnormal Findings Exist
When the provider documents abnormalities during the examination, review whether Z01.411 is more appropriate.
2. Failing to Document the Encounter Purpose
Documentation should clearly establish whether the visit was:
- A routine annual examination
- Cervical cancer screening
- Follow-up care
- Evaluation of symptoms
3. Omitting Abnormal Cytology Diagnoses
When Pap results are abnormal, applicable R87-series codes should be reported when supported by documentation.
4. Using Non-Specific Codes
Always code to the highest degree of specificity supported by clinical records.
5. Ignoring Payer Requirements
Coverage policies for preventive screenings vary among Medicare, Medicaid, and commercial insurers.
Other Preventive Screening Codes Frequently Used During Well-Woman Visits
Women’s preventive healthcare often includes multiple screening services during a single encounter.
| Screening Service | Common ICD-10 Category |
| Cervical cancer screening | Z12.4 |
| Breast cancer screening | Z12.31 |
| STI screening | Z11 Series |
| Venereal disease screening | Z11.3 |
| General wellness examination | Z00.00 / Z00.01 |
Proper documentation helps ensure accurate code assignment and reimbursement.
Why Accurate Pap Smear Coding Matters
Correct diagnosis coding affects more than claim payment.
Accurate coding helps practices:
- Reduce claim denials
- Strengthen compliance efforts
- Support medical necessity
- Improve reimbursement accuracy
- Streamline revenue cycle operations
- Maintain cleaner audit trails
For many healthcare organizations, preventive services represent a significant portion of annual patient encounters. Small coding mistakes can quickly create administrative burdens and lost revenue opportunities.
How Revantage Healthcare Business Solutions Supports Women’s Health Practices
Women’s health providers face growing challenges related to documentation, coding accuracy, payer requirements, prior authorizations, credentialing, and revenue cycle performance.
Revantage Healthcare Business Solutions LLC helps healthcare organizations improve operational efficiency through:
- Medical billing services
- Medical coding support
- Benefits verification
- Prior authorization services
- Credentialing and provider enrollment
- Virtual medical assistant services
- Revenue cycle management solutions
- Data-driven practice performance support
Our team stays current with ICD-10-CM updates, payer policies, and preventive screening requirements to help healthcare organizations improve collections, reduce denials, and maintain compliance.
Frequently Asked Questions
What Is the Correct Pap Smear ICD-10 Code in 2026?
There is no single ICD-10 code for a Pap smear. Commonly used diagnosis codes include Z01.419, Z01.411, Z12.4, and applicable R87-series codes depending on the encounter.
What is the ICD-10 code for a routine well-woman exam?
Z01.419 is commonly reported for routine gynecological examinations without abnormal findings.
What codes are used when abnormalities are found?
Z01.411 may be reported when abnormal findings are discovered during a routine gynecological examination. Additional diagnosis codes should identify the specific abnormality.
What is the ICD-10 code for cervical cancer screening?
Z12.4 is commonly used for encounters involving cervical cancer screening.
What code is used for an abnormal Pap smear?
The appropriate code depends on the documented result. Many abnormal cervical cytology findings are reported using R87-series codes.
Can Z01.419 and Z12.4 be billed together?
In some situations, both diagnosis codes may be reported when a cervical cancer screening is performed during a preventive gynecological examination. Payer policies and documentation requirements should always be reviewed.
Final Thoughts
Selecting the correct ICD-10 code for a Pap smear begins with understanding why the patient was seen.
A routine annual well-woman examination, a screening visit for cervical cancer, and follow-up care after abnormal cervical findings may all involve Pap testing—yet each scenario may require different diagnosis coding.
By focusing on complete documentation, current ICD-10-CM guidance, and payer-specific requirements, healthcare organizations can improve coding accuracy, reduce denials, and support compliant preventive women’s healthcare services in 2026 and beyond.
